Novel use of oral delafloxacin monotherapy in staphylococcal prosthetic valve endocarditis: A case report
{{output}}
Delafloxacin (DLFX), a new anionic fluoroquinolone, has been approved by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of bacterial skin and skin structure infections and by the FDA for community... ...
